Reactions from ABA to views and recommendations for ASD treatments that are not supported by rigorous scientific evidence

The reaction from the broader Applied Behavior Analysis (ABA) community to the views and recommendations for ASD treatments that are not supported by rigorous scientific evidence.

Emphasis on Evidence-Based Practice: BCBAs rely on interventions that have substantial empirical support. They tend to critique approaches that lack such backing, especially those promoted in popular media that could mislead families about the effectiveness and safety of non-validated treatments.

Concerns About Misinformation: Many in the ABA and wider autism treatment communities have expressed concerns about the potential for misinformation to harm individuals with autism. This includes the spread of unsupported claims about vaccine safety and autism causation, as well as unproven treatments.

Advocacy for Scientific Literacy: The BCBA community often emphasizes the importance of scientific literacy among parents and caregivers. They advocate for making treatment decisions based on well-established research to ensure the best outcomes for individuals with ASD.

Professional Responsibility: BCBAs, bound by professional and ethical guidelines, are required to recommend and use treatments that are grounded in science. They often view the promotion of unproven treatments as not only unscientific but also unethical.

Public Education: In response to books like McCarthy's and others promoting alternative treatments, many behavior analysts engage in public education efforts. They aim to provide accurate, research-based information on ASD to counteract popular yet unsupported claims.

Overall, the response from BCBAs tends to focus on maintaining high professional standards, promoting evidence-based treatments, and protecting individuals with ASD from potentially harmful misinformation.